HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qiming Wang Selected Research

Therapeutic Uses

1/2021MEK inhibitors for the treatment of non-small cell lung cancer.
1/2021ATF2 inhibits ani-tumor effects of BET inhibitor in a negative feedback manner by attenuating ferroptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qiming Wang Research Topics

Disease

47Neoplasms (Cancer)
10/2022 - 10/2010
29Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2022 - 07/2010
13Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2022 - 12/2016
13Lung Neoplasms (Lung Cancer)
04/2022 - 03/2012
9Neoplasm Metastasis (Metastasis)
01/2022 - 03/2012
8Disease Progression
10/2022 - 01/2012
8Adenocarcinoma of Lung
06/2022 - 01/2012
7Hypertension (High Blood Pressure)
10/2022 - 11/2018
6Fatigue
10/2022 - 01/2020
5Obesity
01/2021 - 01/2016
5Breast Neoplasms (Breast Cancer)
01/2021 - 01/2016
4Infections
01/2021 - 01/2020
4Esophageal Squamous Cell Carcinoma
01/2019 - 11/2011
3Diarrhea
01/2022 - 01/2019
3Inflammation (Inflammations)
01/2021 - 10/2020
3Carcinoma (Carcinomatosis)
01/2021 - 01/2018
3Lymphatic Metastasis
01/2019 - 08/2014
3Stomach Neoplasms (Stomach Cancer)
09/2015 - 03/2013
2Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 01/2021
2Exanthema (Rash)
01/2022 - 11/2021
2Ovarian Neoplasms (Ovarian Cancer)
08/2021 - 01/2021
2Hepatocellular Carcinoma (Hepatoma)
01/2021 - 01/2020
2Hepatitis B
01/2020 - 01/2019
2Fibrosis (Cirrhosis)
01/2020 - 01/2019
2Hand-Foot Syndrome
01/2019 - 11/2018
2Sleep Initiation and Maintenance Disorders (Insomnia)
01/2019 - 01/2018
2Mucoepidermoid Carcinoma
01/2019 - 05/2017
2Prostatic Neoplasms (Prostate Cancer)
01/2017 - 01/2002
2Radiation Pneumonitis
07/2014 - 03/2013
1Male Breast Neoplasms (Male Breast Cancer)
10/2022
1Retinoblastoma (Glioblastoma, Retinal)
01/2022
1Cardiomegaly (Heart Hypertrophy)
01/2022
1Weight Loss (Weight Reduction)
01/2022
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022
1Brain Neoplasms (Brain Tumor)
01/2022
1Pleural Effusion (Pleural Effusions)
11/2021
1Pre-Eclampsia (Preeclampsia)
11/2021

Drug/Important Bio-Agent (IBA)

13anlotinibIBA
10/2022 - 01/2018
11Tyrosine Kinase InhibitorsIBA
10/2022 - 10/2010
10Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2011
9ErbB Receptors (EGF Receptor)IBA
06/2022 - 10/2010
9Proteins (Proteins, Gene)FDA Link
01/2021 - 08/2014
7Pharmaceutical PreparationsIBA
02/2020 - 05/2015
6PlatinumIBA
04/2022 - 01/2012
6MicroRNAs (MicroRNA)IBA
01/2022 - 03/2012
5Cisplatin (Platino)FDA LinkGeneric
08/2020 - 01/2012
4Long Noncoding RNAIBA
01/2022 - 01/2020
4Gefitinib (Iressa)FDA Link
01/2022 - 01/2012
4Messenger RNA (mRNA)IBA
01/2022 - 01/2017
4CrizotinibIBA
01/2021 - 01/2018
4Anaplastic Lymphoma KinaseIBA
12/2020 - 01/2018
4Small Interfering RNA (siRNA)IBA
01/2017 - 09/2015
3aumolertinibIBA
06/2022 - 01/2022
3Phosphotransferases (Kinase)IBA
06/2022 - 10/2020
3Etoposide (VP 16)FDA LinkGeneric
01/2022 - 01/2021
3osimertinibIBA
10/2021 - 01/2021
3Biological ProductsIBA
01/2021 - 10/2016
3InterferonsIBA
01/2020 - 10/2016
2camrelizumabIBA
01/2022 - 01/2022
2Carboplatin (JM8)FDA LinkGeneric
01/2022 - 02/2015
2Circular RNAIBA
11/2021 - 10/2021
2Immune Checkpoint InhibitorsIBA
08/2021 - 01/2021
2apatinibIBA
02/2021 - 01/2019
2Cell-Free Nucleic AcidsIBA
02/2021 - 10/2019
2Therapeutic UsesIBA
01/2021 - 01/2021
2Capsules (Microcapsules)IBA
01/2021 - 08/2020
2GSK1210151AIBA
10/2020 - 01/2020
2Pro-Opiomelanocortin (Proopiomelanocortin)IBA
10/2020 - 01/2018
2LigandsIBA
08/2020 - 01/2017
2Glucose (Dextrose)FDA LinkGeneric
01/2020 - 01/2017
2CholesterolIBA
01/2019 - 02/2015
2Insulin (Novolin)FDA Link
12/2017 - 01/2017
2SurvivinIBA
10/2016 - 01/2016
23' Untranslated Regions (3' UTR)IBA
09/2015 - 08/2013
1Peptidyl Transferases (Peptidyltransferase)IBA
10/2022
1Tyrosine (L-Tyrosine)FDA Link
06/2022
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2022
1Aspartate-tRNA LigaseIBA
01/2022
1Immunoglobulins (Immunoglobulin)IBA
01/2022
1Monoclonal AntibodiesIBA
01/2022
1Cyclin-Dependent Kinase 4IBA
01/2022
16-methyladenineIBA
01/2022
1Programmed Cell Death 1 ReceptorIBA
01/2022
1EnzymesIBA
11/2021
1B7-H1 AntigenIBA
10/2021
1Histocompatibility Antigens Class IIBA
10/2021
1ginsenoside Rb1IBA
01/2021
1pembrolizumabIBA
01/2021
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2021
1Mitogen-Activated Protein KinasesIBA
01/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021
1Lactic Acid (Lactate)FDA LinkGeneric
01/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021
1Epidermal Growth Factor (EGF)IBA
01/2021
1mitogen and stress-activated protein kinase 1IBA
01/2021
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
01/2021

Therapy/Procedure

34Therapeutics
10/2022 - 10/2010
19Drug Therapy (Chemotherapy)
10/2022 - 01/2012
5Radiotherapy
10/2022 - 03/2013
5Immunotherapy
04/2022 - 05/2019